Michael Marcin Kunz

Suggest Changes
Learn More
This study evaluated the effect of physiological, TSH-guided, L-thyroxine treatment on serum lipids and clinical symptoms in patients with subclinical hypothyroidism. Sixty-six women with proven(More)
OBJECTIVES To evaluate the efficacy of a levonorgestrel-releasing intrauterine system (LNG-IUS) compared with a combined oral contraceptive containing 1 mg norethindrone acetate and 20 mg ethinyl(More)
BACKGROUND The LNG-IUS has increasingly been used for contraception, treatment of menorrhagia and endometrial protection during hormone replacement therapy since mid-1990s. Thus, many women use the(More)
BY KEITH A. BROWNING, ALAN M. BLYTH, PETER A. CLARK, ULRICH CORSMEIER, CYRIL J. MORCRETTE, JUDITH L. AGNEW, SUE P. BALLARD, DAVE BAMBER, CHRISTIAN BARTHLOTT, LINDSAY J. BENNETT, KARL M. BESWICK, MARK(More)
OBJECTIVES The primary aim of this study was to assess the transition from using the levonorgestrel-releasing intrauterine system (LNG IUS, 20 μg LNG/24 h) for reproductive-age contraception to using(More)
BACKGROUND We evaluated the effects of cytochrome P450 3A4 (CYP3A4) induction and inhibition on steady-state pharmacokinetics of the components of a novel oral contraceptive (OC) containing estradiol(More)